Press Release: Syntiron : Syntiron LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Market Research Report

(PR-inside.com) Syntiron LLC (Syntiron) is a biotechnology company that develops human vaccines using iron-regulated bacterial proteins. The company pipeline products include staphylococcus aureus, escherichia coli, bacillus anthracis, burkholderia pseudomallei, yersinia pestis, klebsiella pneumonia. Syntiron provides services such as antigen procurement, fermentation optimization, bioinformatic analysis, transcriptional profiling, qualitative and quantitative protein expression, custom vaccine prototyping, process development, laboratory-scale antigen production, scalable manufacturing, and optimization of adaptive immunity, tailored analytical assay development and live animal imaging services. The company partners with various research and biotechnology companies. Syntiron is headquartered in Saint Paul, Minnesota, the US. Syntiron LLC - Pharmaceuticals & Healthcare - Deals and ..